NCT03720197

Registry of Patients Living With Type 1 Diabetes

Recruiting now Last updated 25 February 2025

What this trial tests

trial testing Online questionnaire - Phase 1 in Type 1 Diabetes Mellitus in 6,000 participants. Currently enrolling.

Timeline

20 February 2019

Primary endpoint
31 March 2027

31 March 2027

Quick facts

Lead sponsor	Institut de Recherches Cliniques de Montreal
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	6,000
Start date	20 February 2019
Primary completion	31 March 2027
Estimated completion	31 March 2027
Sites	7 locations across Canada

Drugs / interventions tested

• Online questionnaire - Phase 1
• Online questionnaire - Phase 2
• Online questionnaire - Phase 3
• Food questionnaire
• Pedometer
• Waist circumference
• Blood and urine tests
• List of medications
• Continuous glucose monitor

Conditions studied

• Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →

Sponsor

Institut de Recherches Cliniques de Montreal — full company profile →

Who can join

Eligibility, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc.

Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

1. Self-reported Severe and Nonsevere Hypoglycemia in Type 1 Diabetes: Population Surveillance Through the BETTER Patient Engagement Registry: Development and Baseline Characteristics.
   Brazeau AS, Messier V, Talbo MK, Gagnon C, et al · · 2022 · cited 34× · PMID 35835670 · DOI 10.1016/j.jcjd.2022.05.010
2. Adaptation of an Adult Web Application for Type 1 Diabetes Self-management to Youth Using the Behavior Change Wheel to Tailor the Needs of Health Care Transition: Qualitative Interview Study.
   Xie LF, Housni A, Nakhla M, Cianci R, et al · · 2023 · cited 10× · PMID 37121571 · DOI 10.2196/42564
3. Influence of severe hypoglycemia definition wording on reported prevalence in adults and adolescents with type 1 diabetes: a cross-sectional analysis from the BETTER patient-engagement registry analysis.
   Madar H, Wu Z, Bandini A, Perkins B, et al · · 2023 · cited 10× · PMID 36245008 · DOI 10.1007/s00592-022-01987-9
4. Gender differences in psychosocial outcomes according to BMI among adults living with type 1 diabetes: A cross-sectional BETTER analysis.
   Bonhoure A, Lalanne-Mistrih ML, Talbo M, Boudreau V, et al · · 2025 · cited 1× · PMID 40535708 · DOI 10.1016/j.jcte.2025.100400